Your search did not produce any results.
Sep 25, 2019

Christoph Stoller Appointed as new President of Medicines for Europe


Republished with permission from Medicines for Europe - 25 September, 2019

Immediately calls on new President of EU Commission to prioritise Healthcare

  • Christoph Stoller (General Manager Germany/Austria for Teva Pharmaceuticals) announced as President of Medicines for Europe for a two-year mandate
  • Priority to address the issue of essential medicines shortages across Europe


First action to call on newly appointed President Elect of European Commission Ursula von der Leyen to establish a new pharmaceutical forum focused on sustainable access to medicines for all EU citizens

May 28, 2019

“There’s a very personal aspect to patient safety”

It can take up to 15 years to develop a new medicine, with rigorous investigations carried out along the way to monitor and improve its effectiveness and safety. But we don’t stop there – we keep monitoring medicines after they become available to patients to check there aren’t any unexpected side effects.

As Teva’s Senior Pharmacovigilance Professional, it’s Vanesa Ivetic Tkalcevic’s job to investigate cases where the unexpected does occur, find out what happened and make recommendations to help keep patients safe in the future.